AB
Allan Buzibye

Publications (9)

A High-Performance Liquid Chromatography-Mass Spectrometry method for simultaneous determination of dolutegravir, nevirapine, efavirenz, rifampicin and rifapentine concentrations in human plasma
Article scientifique · 2025
Dolutegravir use over 48 weeks is not associated with worsening insulin resistance and pancreatic beta cell function in a cohort of HIV-infected Ugandan adults
Article scientifique · 2023
Blood glucose outcomes of anti-retroviral therapy naïve Ugandan people with HIV with pre-diabetes mellitus initiated on dolutegravir for 48 weeks
Article scientifique · 2023
Pharmacopeial quality of artemether–lumefantrine anti-malarial agents in Uganda
Article scientifique · 2023
Relating CYP2B6 genotype and efavirenz resistance among post-partum women living with HIV with high viremia in Uganda: a nested cross-sectional study
Article scientifique · 2023
Blood glucose trajectories and incidence of diabetes mellitus in Ugandan people living with HIV initiated on dolutegravir
Article scientifique · 2023
Prevalence of substandard quality artemether-lumefantrine antimalarial agents in Uganda
Article scientifique · 2022
Relating CYP2B6 Genotype and EFV Resistance Among Women Living With HIV With High Viremia in Uganda: A Nested Cross-Sectional Study.
Article scientifique · 2021
Antiretroviral concentration measurements as an additional tool to manage virologic failure in resource limited settings: a case control study
Article scientifique · 2019

Domaines principaux

Sciences de la santé9

Statistiques

Consultations18
Téléchargements0